TrialBlood2016

Persistence of long-lived plasma cells and humoral immunity in individuals responding to CD19-directed CAR T-cell therapy.

Vijay G Bhoj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.